Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Erythema multiforme after initiating spesolimab in a patient with generalized pustular psoriasis with IL36RN mutation.

European journal of dermatology : EJD - 1 Jun 2024

Nakajima Hideyuki, Kamata Masahiro, Okada Yoshiki, Ito Makoto, Watanabe Ayu, Azuma Saori, Uchida Hideaki, Egawa Shota, Chijiwa Chika, Hiura Azusa, Fukaya Saki, Hayashi Kotaro, Fukuyasu Atsuko, Tanaka Takamitsu, Ishikawa Takeko, Sugiura Kazumitsu, Tada Yayoi

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Interleukins
Mutation
Psoriasis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39015980
DOI: 10.1684/ejd.2024.4711

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Erythema multiforme after initiating spesolimab in a patient with generalized pustular psoriasis with IL36RN mutation.PMID 39015980Read ↗

Spesolimab for generalized pustular psoriasis: a prospective study with a 6-month follow-up.Semantic proximity Read ↗

Clinical advances in biological therapy for generalized pustular psoriasis: a review.Semantic proximity Read ↗

Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations.Semantic proximity Read ↗

Generalized pustular psoriasis-like drug eruption manifested by systemic glucocorticosteroid in a patient without IL36RN mutation or an immunological disorder.Semantic proximity Read ↗

Flare-up of generalized pustular psoriasis following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: Two cases without mutations of IL36RN and CARD14 genes.Semantic proximity Read ↗

IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasisSemantic proximity Read ↗

Generalized pustular psoriasis: immunological mechanisms, genetics, and emerging therapeutics.Semantic proximity Read ↗

Generalized Pustular Psoriasis With IL-36 Receptor Antagonist Mutation Successfully Treated With Granulocyte and Monocyte Adsorption Apheresis Accompanied by Reduced Serum IL-6 Level.Semantic proximity Read ↗

Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.Semantic proximity Read ↗

An update on genetic basis of generalized pustular psoriasis (Review).Semantic proximity Read ↗

Mutations in IL36RN in Patients with Generalized Pustular PsoriasisSemantic proximity Read ↗

Case report: Successful treatment with spesolimab of acrodermatitis continua of Hallopeau in an older patient without IL36RN mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.